Anrukinzumab
Product Specifications
CAS Number
910649-32-0
Target
IL Receptor, Interleukin
Related Pathways
Immunology/Inflammation
Purity
0.983
Bioactivity
Anrukinzumab (IMA-638) is a humanized monoclonal antibody that specifically targets and neutralizes interleukin-13 (IL-13) . Anrukinzumab has demonstrated significant anti-inflammatory effects in validated non-human primate models of disease, supporting its ongoing research for the treatment of ulcerative colitis (UC) and asthma.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC941239-100 1x 100 µL
Napsin-A (NAPSA/1239), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNUB0026-100 1x 100 µL
ACTH (Adrenocorticotrophic Hormone) (AH26), 0.2mg/mL
Sign In for Pricing
View Details